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Introduction
In a recent paper we reported a study of the volatile 
biomarkers in breath associated with liver disease 
using proton transfer reaction mass spectrometry 
(PTR-MS) [1]. The results of that study strongly 
suggest that three volatiles, methanol, 2-pentanone 
and limonene, are related to a diseased liver. The risk 
of false discovery was minimised by using a two stage 
process to reduce the variable set so that we did not 
have to rely on unsupervised multivariate analysis. 
Importantly, for this present work 12 of the 31 
patients investigated in the first stage, which involved 
comparing breath samples of patients suffering with 
chronic liver disease with 30 healthy controls (usually 
partners of the ill patients), had their breath analysed 
post liver transplant. Of these 12 patients, 5 were 
followed longitudinally as in-patients during the post-
transplant period for a number of weeks. For all 12 
patients, a number of ions were observed in the proton 
transfer reaction mass spectra of the post-transplant 
breath samples, which were not present in the pre-
transplant breath samples. We considered that these 
result from a reaction of H3O+ with the anaesthetic, 
isoflurane, (C3H2ClF5O) used during surgery. In 
agreement with this, one of the ions that we observe 
at m/z 165, has been assigned to be +CF HOCHClCF2 2  
from a Selected Ion Flow Tube-MS (SIFT-MS) analysis 
R Fernández del Río et al
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Abstract
Isoflurane (1-chloro-2,2,2-trifluoroethyl difluoromethyl ether), C3H2ClF5O, is a commonly used 
inhalation anaesthetic. Using a proton transfer reaction mass spectrometer (PTR-MS) we have 
detected isoflurane in the breath of patients several weeks following major surgery. That isoflurane 
is detected in the breath of patients so long after being anaesthetised raises questions about when 
cognitive function has fully returned to a patient. Temporal profiles of isoflurane concentrations in 
breath are presented for five patients (F/M 3/2, mean age 50 years, min–max 36–58 years) who had 
undergone liver transplant surgery. In addition, results from a headspace analysis of isoflurane are 
presented so that the product ions resulting from the reactions of H3O+ with isoflurane in PTR-
MS could be easily identified in the absence of the complex chemical environment of breath. Six 
product ions were identified. In order of increasing m/z (using the 35Cl isotope where appropriate) 
these are +CHF2  (m/z 51), CHFCl
+ (m/z 67), CF3CHCl+ (m/z 117), C3F4OCl+ (m/z 163), 
C3H2F4OCl+ (m/z 165), and C3F4OCl+ H2O (m/z 183). No protonated parent was detected. For the 
headspace study both clean air and CO2 enriched clean air (4% CO2) were used as buffer gases in 
the drift tube of the PTR-MS. The CO2 enriched air was used to determine if exhaled breath would 
affect the product ion branching ratios. Importantly no significant differences were observed, and 
therefore for isoflurane the product ion distributions determined in a normal air mixture can be 
used for breath analysis. Given that PTR-MS can be operated under different reduced electric fields 
(E/N), the dependence of the product ion branching percentages for isoflurane on E/N (96–138 Td) 
are reported.
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of the headspace of isoflurane with H3O+ as the 
reagent ion [2].
Given our longitudinal measurements, which pro-
vide mass spectra of post-transplant breath samples 
for several weeks after the operation, we had a unique 
opportunity to investigate how long isoflurane remains 
in the body of unhealthy patients following major sur-
gery. This may have consequences in terms of the intel-
lectual function of patients by providing details on how 
quickly patients can safely return to a normal life.
Other PTR-MS studies have either concentrated on 
monitoring an intravenous anaesthetic, propofol, dur-
ing surgery [3–8] or for monitoring sevoflurane and 
isoflurane in the hospital environment, namely in an 
urological post-anaesthesia care unit [9] and for sevo-
flurane in an operating theatre [10].
There have been several other studies investigating 
the elimination of volatile anaesthetics from the body 
following surgery. Yasuda et al [11] used gas chroma-
tography with flame ionisation detection (GC-FID) to 
compare the kinetics of sevoflurane and isoflurane in 
humans. Of relevance to our study they report a fast 
elimination of isoflurane from the body, namely within 
a day the breath concentrations had decreased by an 
order of magnitude. However, their work used seven 
healthy male volunteers (mean age of 23 years with a 
standard deviation of 3 years). Therefore, the rapid 
decrease in concentration may not be a true reflection 
of what happens with sick, obese and/or older people. A 
more recent paper by Ghimenti et al [12] reports details 
on a study using GC-MS of post-operative elimina-
tion of sevoflurane and its metabolite, hexafluroiso-
propanol, in exhaled breath of six very sick patients 
that had undergone a variety of surgeries. They used 
pharmokinetic models for assessing liver function. 
In their investigations mixed-expired breath samples 
(multiple deep breaths) were collected in disposable 
Nalophan bags. The samples were then transferred 
to desorption tubes for subsequent analysis. Here we 
report the first PTR-MS longitudinal study investigat-
ing isoflurane in the breath of patients following sur-
gery. Prior to being able to analyse the mass spectra of 
the post-transplant breath samples, it was necessary to 
establish which product ions result from the reaction of 
H3O+ with isoflurane in the drift tube environment of a 
PTR-MS, divorced from the complex chemical environ-
ment of breath. Therefore, as part of this study we pre-
sent a headspace analysis of isoflurane at the reduced 
electric field of 136 Td used in our previous liver study. 
Given that the product ions found in this study differ 
from those by Wang et al [2], we also present the prod-
uct ion branching ratios over an extended reduced elec-
tric field from approximately 90 Td through to 140 Td. 
These have been determined using both clean air and 
CO2 enriched clean air, to mimic breath, as the buffer 
gases in the drift tube of our PTR-MS. The use of CO2 
enriched air is important because the presence of a high 
percentage of CO2 could influence the proton transfer 
reaction leading to different product ion distributions, 
which need to be taken into account when analysing 
breath samples [13, 14].
Experimental details and methods
Headspace analysis
Isoflurane (CAS Number 26675-46-7) was purchased 
from Sigma Aldrich (UK).
Isoflurane samples were prepared for analysis by 
adding 1 µl of isoflurane into a 100 ml glass bottle. A 
100 ml glass syringe was then coupled to the top part of 
the bottle using a 3-way luer-lock stopcock and 10 ml of 
the isoflurane headspace gas was sampled. The isoflu-
rane sample was then diluted in the glass syringe with 
90 ml of clean air or CO2 enriched clean air (4% carbon 
dioxide, 17% oxygen and 79% nitrogen (Scientific and 
Technical Gases Ltd (STG, Staffordshire, UK)). The 
concentration of the isoflurane was sufficiently low that 
no depletion of the H3O+ signal was observed.
Patients
Patients were recruited at the University Hospital 
Birmingham from the transplant assessment clinic. 
Of the 31 patients who consented to take part in the 
clinical trial, 12 went on to have liver transplant. Of 
these we were able to follow five patients for several 
weeks following surgery (F/M 3/2, mean age 50 years, 
min–max 36–58 years). Table 1 summarises the 
details of these five patients, with each patient being 
just identified by sex (F or M) and a number, which 
was used in our previous study and retained here for 
comparison [1]. Note that the number of samples 
and days at which breath samples were taken varies 
because of the availability and health of the patient. 
Patients were followed from the Intensive Care Unit 
after their transplant, through to the wards until 
their discharge. Some patients recovered and were 
discharged quicker than others so there are fewer data 
points for them.
In addition to taking breath samples from controls 
as described in [1], samples of air in the locations where 
the patients were in, were collected so that allowances 
for any background isoflurane could be taken into 
account.
Hospital room air was collected every time breath 
samples were taken using glass syringes (2 syringes for 
every sample), which were analysed in the same way as 
the breath samples. Our data relating to isoflurane con-
centrations in the hospital environment show that the 
maximum concentration for any of the sampling days 
was at 4 ppbv. There was one exception to this when 
13 ppbv was measured for one patient, F4, who was in a 
small enclosed room with poor ventilation, and there-
fore the patient was almost certainly contaminating the 
air with her own breath. Thus any contribution to the 
isoflurane signal from the environment is negligible 
compared to that in the breath.
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Breath sampling protocol
A detailed description of the breath sampling protocol 
used can be found in our earlier paper dealing with 
volatiles associated with liver disease [1]. In brief, 
capnography controlled sampling was used to 
collect only the alveolar phase of the breath. Subjects 
were seated and in a relaxed state and were asked to 
breathe normally into a gas tight respiratory system 
(Intersurgical Limited) containing an in-line CO2 
mainstream sensor connected to a fast-time response 
capnometer (Capnogard 1265 Novametrix Medical 
Systems Inc.). A 100 ml glass syringe (Sigma-Aldrich) 
was coupled to the tubing using a 3-way luer-lock 
stopcock (Braun Medical Limited). When the alveolar 
plateau on the capnograph was observed, the breath 
sample was manually drawn from the subject’s breath 
stream into the syringe. Three to four breaths samples 
were collected into each 100 ml syringe, and four 
replicates of these were taken for each subject. Glass 
syringes were used, because our tests showed that they 
minimize surface adsorption. We avoided the use of 
bags owing to potential problems associated with losses 
and ageing effects [15].
Within two hours after collection, breath samples 
were mass spectrometrically analyzed by PTR-MS, 
for which the syringes were maintained at a constant 
temperature of 40 °C using a heating bag (Infroheat, 
Wolverhampton). This was done to limit condensa-
tion, which could otherwise lead to volatile loss [16]. 
The outlet from each syringe was connected directly 
to the inlet of the PTR-MS. Within two hours we have 
found that there is no significant loss of isoflurane in 
the syringe.
Analytical measurements
PTR-MS is a technology designed to detect low 
concentrations of volatiles (less than parts per billion 
by volume). Hence it has found use in many analytical 
applications ranging from drug detection through to 
industrial pollution [17]. Details of the instrument used, 
a first generation PTR-Quad-MS (IONICON Analytik 
GmbH), and how it operates are described in detail in 
the literature [17, 18]. In brief, it exploits the reactions 
of protonated water with neutral volatiles (M), often 
leading to a protonated parent (MH+). If dissociative 
proton transfer occurs then it is not extensive in terms 
of the number of resulting product ions. The drift tube 
was maintained at 2.07  ±  0.01 mbar and temperature 
of 45  ±  1 °C. For the breath analysis the drift-tube 
voltage was set at the standard recommended value of 
600 V. For the headspace analysis the voltage across the 
drift-tube was changed from 400 V to 600 V at intervals 
of 20 V, E/N (96–138 Td).
Mass spectra of the breath samples were recorded 
and the areas under the spectral peaks converted to a 
volume mixing ratio (VMR) by use of a standard pro-
cedure that relies on the use of an experimentally meas-
ured reaction rate coefficient and reagent and product 
ion counts [17].
Results and discussion
Headspace analysis of isoflurane
No protonated isoflurane (m/z 185) was observed for 
any value of the reduced electric field. This agrees with 
the results of Wang et al who conclude that once formed 
the excited protonated parent spontaneously dissociates 
via various pathways [2]. However, in comparison to 
Wang et al SIFT-MS (thermal energy) measurements, 
we find substantial differences in product ions and 
their branching ratios. In our measurements we 
have observed primary product ions at m/z 51, m/z 
67, m/z 117, m/z 163, and m/z 165. By taking into 
account isotopic abundance we have assigned these 
to be +CHF2 , CHFCl
+, CF3CHCl+, C3F4OCl+, and 
C3H2F4OCl+, respectively. Another ion involving 
isoflurane is observed at m/z 181 which is assigned as 
a secondary (association) reaction of C3F4OCl+ with 
H2O. The product ion percentage branching ratios at 
a commonly used reduced electric field of 138 Td are 
presented in table 2 and compared to the measurements 
of Wang et al.
Wang et al observed no m/z 51 ions. This almost cer-
tainly results from the differences in collisional ener-
gies and possibly the internal energy of the H3O+ ions, 
both of which are considered to be at thermal energies 
in SIFT-MS systems. Certainly we only observe a signifi-
cant branching ratio for this ion at 138 Td. The supple-
mentary information (stacks.iop.org/JBR/10/046006/
mmedia) provides details on the product ion branch-
ing ratios as a function of reduced electric field. This 
is provided because different PTR-MS users use dif-
ferent reduced electric fields and also because of the 
major differences observed in the product ions and 
branching ratios compared to the only other headspace 
analysis by Wang et al also observed product ions at m/z 
Table 1. Liver transplant patient details, including sex (female F, male M), age, location of post-transplant breath sampling  
(Out-Patient Clinic (OPC) or Ward), and number of days after transplant when breath samples were collected.
Patient ID Age (year)
Location of post-transplant  
breath sample
Post-transplant breath samples: 
days after transplant
F2 49 OPC 3, 5, 130
F4 58 Ward 5–8, 11–15, 18, 58
F5 53 Ward 2–6, 9–12
M3 53 Ward 4, 7, 48
M7 36 Ward 2, 3, 6–8, 55
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67, but assign it to be CF2HO+ rather than CHFCl+, 
m/z 99 (assigned to be CF3CH2O+), which we did not 
observe, m/z 117 (CF3CHCl+, in agreement with our 
assignment), m/z 119 ( +CF CFHOH3 2 ), which we do not 
observe other than the 37Cl isotope of CF3CHCl+, m/z 
147 (CF2HOCHClCH+), which we do not observe, and 
m/z 165 (C3H2F4OCl+).
Given that the product ion branching ratios were 
obtained using normal air in the drift tube, a question 
remains as to whether the presence of higher CO2 con-
centrations in breath could affect these ratios through 
thermalisation effects as a result of collisions of H3O+ 
with CO2 prior to reaction with isoflurane. This is an 
important issue for breath analysis using PTR-MS. Keck 
et al [14] have already demonstrated that higher CO2 
concentrations in the drift tube buffer gas of a PTR-
MS enhances the concentration ratio of the protonated 
water dimer to protonated water and changes the mass 
spectra of key breath gases such as methanol, ethanol, 
1-propanol, 2-propanol, acetone and isoprene. We 
therefore undertook a headspace analysis using CO2 
enriched (4%) air in the drift tube to determine if the 
product ion distributions associated with isoflurane 
would be altered when analysing the breath samples. We 
find that within experimental uncertainty no signifi-
cance difference in product ion percentage branching 
ratios is observed between normal and CO2 enriched air 
buffer gases (see supplementary information). There is 
still a question of changes in humidity [2], but that will 
be the subject of another study.
Longitudinal measurements of isoflurane in breath 
samples post liver transplant
By using the product ions and their branching ratios 
determined in the headspace analysis we can determine 
the isoflurane concentrations in breath by adding the 
intensities of all product ions that result from the 
reaction of H3O+ with isoflurane at a reduced electric 
field of 138 Td, namely m/z 51, m/z 67 (69), m/z 117 
(119), m/z 163 (165), and m/z 165 (167). It should be 
noted that the m/z 69 signal intensity cannot be used 
directly owing to the presence of isoprene in human 
breath. Therefore the total ion signal associated with 
CHFCl+ is determined only from the m/z 67 ion 
intensity. However, it is important to point out that since 
isoflurane in breath results in a spectral peak at m/z 69 
(CHF37Cl+) there are consequences for any PTR-MS 
studies which monitor isoprene in the breath following 
a surgical procedure during which isoflurane is used. 
The contribution of isoflurane to the signal intensity at 
m/z 69 was found to be significant and varied between 
12% to 99% at the beginning of our longitudinal study, 
being dependant on the concentration found in a 
patient’s breath.
Figure 1 shows the temporal changes in isoflurane 
concentrations for the five patients: F2, F4, F5, M3 
and M7. The important observation is that we did not 
observe rapid decreases in isoflurane concentrations 
following surgery. This is different from the results of 
Yasuda et al who found that the elimination of isoflu-
rane from the human body was fast [10], i.e. within 
one day the signal intensity had been observed to have 
dropped by about an order of magnitude, whereas in 
our study we still found high concentrations of iso-
flurane in the breath several days after the operation. 
Although the Yasuda et al study used healthy young 
male subjects (age 23  ±  3 years (mean  ±  sd)), the 
observed temporal difference is still surprising given 
that the major elimination of isoflurane is through 
breath. Isoflurane is poorly metabolised (0.17%) by 
hepatic cytochrome P450 enzymes in the liver [19].
A possible explanation for the observed difference 
between our results and those of Yasuda et al could 
be associated with the physical condition of the sub-
jects/patients involved and the duration of isoflurane 
administration. Yasuda et al volunteers were healthy 
and had a mean body mass index (BMI) of 21.7 kg m−2, 
i.e. all were within the normal (healthy weight) range. 
In comparision F2, F4, F5, M3 and M7 had BMIs of 
31.2, 32.4, 28.0, 32.5, and 35.0 kg m−2, respectively. 
Thus our patients were either overweight or obese. 
Furthermore, Yasuda et al administered isoflurane for 
precisely 30 min, whereas our patients underwent sur-
geries that lasted between 5 to 7 h. Although isoflurane 
has a low blood/gas partition coefficient of 1.45  ±  0.12 
(mean  ±  SD) [20], it has a high oil/blood partition 
coefficient of 97, and therefore we propose that for 
our patients a significant amount of the isoflurane was 
absorbed into fat tissue, only to be slowly released after 
surgery. In support of this argument, it has been found 
that if isoflurane is administered for more than 2 h, as 
would be the case for our patients, the adipose tissue 
becomes saturated and then the emergence from the 
anaesthetic is prolonged [21].
Finally, we comment that of all our patients, patient 
M7 showed the fastest elimination of isoflurane even 
though he had the highest concentration in exhaled 
Table 2. m/z values (dominant ion peak), proposed product ions 
and branching ratio percentages resulting from the reaction of 
H3O+ with isoflurane using PTR-MS (reduced electric field of  
138 Td) and SIFT-MS [2]. 
m/z
Proposed  
product ion % PTR-MS % SIFT-MS [2]
51 CHF2
+ 12 —
67 CF2HO+ — 15
67 CHFCl+ 50 —
99 CF3CH2O+ — 10
117 CF3CHCl+ 6 30
119 CF CFHOH3 2
+ — 25
147a CF3HOCHClCH+ — 10
163 CF3CClOCF+ 24 —
165 CF HOCHClCF2 2
+ 8 10
a In the paper by Wang et al the ion at m/z 147 is incorrectly given 
as CF2HOCHClCH+.
Note: The percentages have taken into account the 37Cl isotope for 
the chlorine containing ions. For the PTR-MS studies the product 
ion branching percentages have an error of approximately  ±20%.
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breath after surgery and was the most obese patient. 
However, the elimination was still much less than found 
in the study of Yasuda’s study. The rapid washout, in 
comparison to the other patients, could be a result of 
this patient being the youngest of the group involved at 
36 years old. (F2, F4, F5 and M3 ages were 49, 58, 53 and 
53 years, respectively.) M7 also recovered from surgery 
more quickly than the other patients in this group and 
was discharged within one week. However, with such a 
small number of patients we cannot state whether or 
not there is any correlation with age and perhaps gender 
with regards to isoflurane elimination from fatty tissue. 
More detailed studies are therefore required.
Conclusions
An aim of this study was to determine which product 
ions result from the reaction of H3O+ with isoflurane 
in order to monitor isoflurane in the breath. No 
protonated parent was observed, instead the protonated 
parent rapidly fragments to diagnostically useful ions 
with m/z values of 67 (69), 117 (119), 163 (165) and 165 
(167), which are assigned to be CHFCl+, CF3CHCl+, 
C3F4OCl+ and C3H2F4OCl+ respectively. Using 
these ions, the wash out characteristics of isoflurane 
following liver transplant have shown that a patient will 
still have high levels of isoflurane in their blood even 
several days after the operation. This could have an 
impact on a patient’s ability to drive and use machines 
after isoflurane anesthesia administration, especially 
after a long operation, when isoflurane will be stored 
in fat tissue.
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